Inventor · disambiguated record
Ami Patel
Also filed as: PATEL AMI · PATEL AMI C
12 granted patents·15 pending applications·10 citations·filing 2009–2025
85Inventor score
Files withUNIV PENNSYLVANIA8WISTAR INST5INOVIO PHARMACEUTICALS INC4WEINER DAVID3CLAYTON PHARMACEUTICALS LLC2
Top patents by PatentIndex Score
27 records- 0193US11660335B2Vaccines against coronavirus and methods of useINOVIO PHARMACEUTICALS INC·Filed 2021·Granted May 30, 2023·2 cites·21 claims
- 0286US11091518B2Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using sameUNIV PENNSYLVANIA·Filed 2017·Granted Aug 17, 2021·2 cites·24 claims
- 0383US2025121054A1Vaccines against coronavirus and methods of useINOVIO PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0482US11596678B2Marburgvirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using sameUNIV PENNSYLVANIA·Filed 2017·Granted Mar 7, 2023·2 cites·18 claims
- 0579US12162925B2DNA-encoded monoclonal antibodies targeting the Ebolavirus glycoproteinWISTAR INST·Filed 2018·Granted Dec 10, 2024·1 cites·13 claims
- 0677US9989519B1Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (RLD)CLAYTON PHARMACEUTICALS LLC·Filed 2017·Granted Jun 5, 2018·3 cites·23 claims
- 0776US2023338515A1Vaccines against coronavirus and methods of useINOVIO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0875US12240872B2Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using sameUNIV PENNSYLVANIA·Filed 2021·Granted Mar 4, 2025·0 cites·17 claims
- 0974US12268735B2Marburgvirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using sameUNIV PENNSYLVANIA·Filed 2023·Granted Apr 8, 2025·0 cites·20 claims
- 1072US2024150442A1DNA Monoclonal Antibodies Targeting Influenza VirusUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1171US2025257101A1Filovirus Consensus Antigens, Nucleic Acid Constructs and Vaccines Made Therefrom, and Methods of Using SameUNIV PENNSYLVANIA·Filed 2025·Application pending·0 cites
- 1264US2024409619A1Antibodies for use against sars-cov-2WEINER DAVID·Filed 2022·Application pending·0 cites
- 1364US2024409618A1DNA ENCODED ANTIBODIES WITH Fc MODIFICATIONSWEINER DAVID·Filed 2022·Application pending·0 cites
- 1459US2022370598A1Vaccines Against Coronavirus and Methods of UseINOVIO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1558US2024287166A1Dna antibody constructs for use against plasmodium parasitesWEINER DAVID·Filed 2022·Application pending·0 cites
- 1657US11851477B2DNA monoclonal antibodies targeting influenza virusWEINER DAVID B·Filed 2017·Granted Dec 26, 2023·0 cites·16 claims
- 1755US2023210981A1Coronavirus disease 2019 (covid-19) combination vaccineWISTAR INST·Filed 2021·Application pending·0 cites
- 1854US8404243B2Peptide adjuvantsPATEL AMI·Filed 2009·Granted Mar 26, 2013·0 cites·10 claims
- 1953US2024016919A1INTRADERMAL MERS-CoV VACCINEWISTAR INST·Filed 2021·Application pending·0 cites
- 2051US12492243B2DNA antibody constructs for use against Pseudomonas aeruginosaUNIV PENNSYLVANIA·Filed 2017·Granted Dec 9, 2025·0 cites·15 claims
- 2149US2021148893A1Method for determining in vitro bioequivalence of a sucralfate suspension sample to a sucralfate suspension reference listed drug (rld)CLAYTON PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 2249US2023063151A1Cd40-l blockade to enhance synthetic antibody therapyWISTAR INST·Filed 2021·Application pending·0 cites
- 2348US12110342B2Nucleic acid monoclonal antibodies targeting PCSK9 and methods of useWISTAR INST·Filed 2019·Granted Oct 8, 2024·0 cites·14 claims
- 2446US2019290750A1Dna antibody constructs for use against ebola virusUNIV PENNSYLVANIA·Filed 2017·Application pending·0 cites
- 2545US9211325B2Peptide adjuvantsPATEL AMI·Filed 2013·Granted Dec 15, 2015·0 cites·9 claims
- 2639US2019091322A1Dna antibody constructs and method of using sameWEINER DAVID B·Filed 2017·Application pending·0 cites
- 2737US2019031743A1Screening methods for identifying antibodies that bind cell surface epitopesACHAOGEN INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ami Patel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →